Zeo ScientifiX (ZEOX) Income from Non-Controlling Interests (2017 - 2019)
Zeo ScientifiX (ZEOX) posted quarterly Income from Non-Controlling Interests of -$298.0 for Q3 2019, up 12.35% year-over-year from -$265.24 in Q3 2018, and up 12.35% quarter-over-quarter from -$340.0 in Q2 2019.
Zeo ScientifiX (ZEOX) Income from Non-Controlling Interests (2017 - 2019) Analysis & Trends
Zeo ScientifiX's Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$298.0 for Q3 2019.
- In Q3 2019, Income from Non-Controlling Interests rose 12.35% year-over-year to -$298.0; the TTM figure through Apr 2020 stood at -$298.0 (up 78.1% YoY), while the FY2019 annual figure was -$978.0, down 103.18% from the prior year.
- Income from Non-Controlling Interests for Q3 2019 stood at -$298.0, up from -$340.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $55464.0 in Q2 2018, with the low at -$56065.0 in Q4 2017.
- The 3-year median for Income from Non-Controlling Interests is -$340.5 (2018), against an average of -$11062.0.
- The sharpest annual moves came in 2018 and 2019: Income from Non-Controlling Interests jumped 247.7% in 2018, then tumbled 100.61% in 2019.
- Zeo ScientifiX's Income from Non-Controlling Interests stood at -$56065.0 in 2017, then jumped by 99.39% to -$341.0 in 2018, then increased by 12.61% to -$298.0 in 2019.
- Business Quant data shows ZEOX's Income from Non-Controlling Interests at -$298.0 in Q3 2019, -$340.0 in Q2 2019, and -$340.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 63.60 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2019 | -298.00 |
| Apr 30, 2019 | -340.00 |
| Jan 31, 2019 | -340.00 |
| Oct 31, 2018 | -341.00 |
| Jul 31, 2018 | -340.00 |
| Apr 30, 2018 | 55,464.00 |
| Jan 31, 2018 | -24,038.00 |
| Oct 31, 2017 | -56,065.00 |
| Jul 31, 2017 | -46,769.00 |
| Apr 30, 2017 | -37,553.00 |